INBX
INBX
US45720N1037
Inhibrx Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.300.000 200.000
550.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
136.325.000 331.648.000
58.9%
Operating Income -135.025.000 -331.448.000
59.3%
Pretax Income -140.053.000 1.687.574.000
108.3%
Net Income Common Stockholders -140.055.000 1.687.572.000
108.3%
-- --
--
-- --
--
ende